Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation

27 August 2021 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Giuseppe d'ancona

Vivantes Klinikum Am Urban, Berlin (Germany)

160 More presentations in this session

Presentation thumbnail

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Associate Professor T. Mine (Nishinomiya, JP)

Abstract Slides

Presentation thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Doctor M. Sugitani (Nishinomiya, JP)

Abstract Slides

Presentation thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Mr T. Klamer (Amsterdam, NL)

Abstract Slides

Presentation thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Doctor M. Mansour (Beirut, LB)

Abstract Slides

Presentation thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Doctor C. Boerschel (Hamburg, DE)

Abstract Slides

Access the full session

Session thumbnail

Atrial fibrillation e-posters

The Event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

You may be interested in

Congress Presentation

Left atrial appendage closure in atrial fibrillation: gaps in knowledge

Congress Presentation

Pros and cons of endocardial left atrial appendage closure

Congress Session

Stroke prevention in atrial fibrillation: do not forget the left atrial appendage!

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources